GB1592272A - Fused thiazolidine derivatives and process for their manufacture - Google Patents

Fused thiazolidine derivatives and process for their manufacture Download PDF

Info

Publication number
GB1592272A
GB1592272A GB37523/77A GB3752377A GB1592272A GB 1592272 A GB1592272 A GB 1592272A GB 37523/77 A GB37523/77 A GB 37523/77A GB 3752377 A GB3752377 A GB 3752377A GB 1592272 A GB1592272 A GB 1592272A
Authority
GB
United Kingdom
Prior art keywords
compound
chloro
hydroxy
indano
thiazolidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB37523/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of GB1592272A publication Critical patent/GB1592272A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/84Naphthothiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
GB37523/77A 1976-09-08 1977-09-08 Fused thiazolidine derivatives and process for their manufacture Expired GB1592272A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762640358 DE2640358A1 (de) 1976-09-08 1976-09-08 Thiazolidinderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
GB1592272A true GB1592272A (en) 1981-07-01

Family

ID=5987411

Family Applications (1)

Application Number Title Priority Date Filing Date
GB37523/77A Expired GB1592272A (en) 1976-09-08 1977-09-08 Fused thiazolidine derivatives and process for their manufacture

Country Status (20)

Country Link
US (1) US4174397A (US06858664-20050222-C00036.png)
JP (1) JPS5334771A (US06858664-20050222-C00036.png)
AT (2) AT365181B (US06858664-20050222-C00036.png)
AU (1) AU509651B2 (US06858664-20050222-C00036.png)
BE (1) BE858520A (US06858664-20050222-C00036.png)
CA (1) CA1089458A (US06858664-20050222-C00036.png)
DE (1) DE2640358A1 (US06858664-20050222-C00036.png)
DK (1) DK397777A (US06858664-20050222-C00036.png)
ES (1) ES462065A1 (US06858664-20050222-C00036.png)
FI (1) FI772642A (US06858664-20050222-C00036.png)
FR (1) FR2364219A1 (US06858664-20050222-C00036.png)
GB (1) GB1592272A (US06858664-20050222-C00036.png)
HU (1) HU175751B (US06858664-20050222-C00036.png)
IT (1) IT1084414B (US06858664-20050222-C00036.png)
NL (1) NL7709697A (US06858664-20050222-C00036.png)
NO (1) NO773094L (US06858664-20050222-C00036.png)
NZ (1) NZ185105A (US06858664-20050222-C00036.png)
PT (1) PT67014B (US06858664-20050222-C00036.png)
SE (1) SE7710084L (US06858664-20050222-C00036.png)
ZA (1) ZA775405B (US06858664-20050222-C00036.png)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59210039A (ja) * 1983-05-16 1984-11-28 Kirin Brewery Co Ltd 2−ブロモ−1−テトラロン誘導体およびその用途
JPS6297769A (ja) * 1985-10-23 1987-05-07 Kobe Steel Ltd 溶接管の製造方法
MY106964A (en) * 1988-04-28 1995-08-30 Schering Corp Fused polycyclic compounds, compositions, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents.
DE19736922A1 (de) * 1997-08-25 1999-03-04 Bayer Ag Verfahren zur Herstellung von 2-Halogenindan-1-onen
DE19736921A1 (de) * 1997-08-25 1999-03-04 Bayer Ag Verfahren zur Herstellung von 2-Cyanoindan-1-onen
DE19831878C2 (de) * 1998-07-17 2001-05-17 Aventis Pharma Gmbh Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19844547C2 (de) * 1998-09-29 2002-11-07 Aventis Pharma Gmbh Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908535A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen Thiazol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE19908537A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen 2-Amino-Thiazol Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE19908538A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Thiazol Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
DE19908539A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Dihydrothiazolsysteme, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908533A1 (de) 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische Thiazol-Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
DE19908536A1 (de) 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische Thiazol-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
WO2001032638A1 (de) * 1999-11-05 2001-05-10 Aventis Pharma Deutschland Gmbh Indeno-, naphtho- und benzocyclohepta-dihydrothiazol derivate, deren herstellung und deren verwendung als anorektische arzneimittel
DE10008274A1 (de) * 2000-02-23 2001-08-30 Aventis Pharma Gmbh Substituierte 8,8a-Dihydro-3aH-indeno[1,2-d]thiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP1259498B1 (de) * 2000-02-23 2004-11-24 Aventis Pharma Deutschland GmbH 8,8a-dihydro-indeno [1,2-d]thiazol-derivate, die in 8a-stellung substituiert sind, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel z.b. als anorektika
AU2001244136B2 (en) * 2000-02-26 2005-04-14 Sanofi-Aventis Deutschland Gmbh 8,8a-dihydro-indeno[1,2-d]thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, method for production thereof and use thereof as medicament
DE10142661B4 (de) 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel
DE10142722A1 (de) 2001-08-31 2003-03-27 Aventis Pharma Gmbh C2-substituierte Indan-1-one und ihre Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10142665B4 (de) * 2001-08-31 2004-05-06 Aventis Pharma Deutschland Gmbh C2-Disubstituierte Indan-1-one und ihre Derivate
DE10142667B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel
DE10142662B4 (de) 2001-08-31 2004-07-08 Aventis Pharma Deutschland Gmbh Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel
JP6204583B2 (ja) * 2014-05-15 2017-09-27 富士フイルム株式会社 α−ブロモアセトフェノン化合物の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507868A (en) * 1968-10-21 1970-04-21 Sandoz Ag Imidazo(2,1-b)thiazoles and thiazolo(3,2-a)pyrimidines
DE2436263C2 (de) * 1974-07-27 1983-02-17 Hoechst Ag, 6000 Frankfurt Thiazolidinderivate und Verfahren zu ihrer Herstellung
DE2533821A1 (de) * 1975-07-29 1977-02-17 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
PT67014A (de) 1977-09-30
AU2865777A (en) 1979-03-15
DK397777A (da) 1978-03-09
CA1089458A (en) 1980-11-11
FR2364219B1 (US06858664-20050222-C00036.png) 1980-06-20
IT1084414B (it) 1985-05-25
BE858520A (fr) 1978-03-08
FI772642A (fi) 1978-03-09
NO773094L (no) 1978-03-09
AU509651B2 (en) 1980-05-22
ATA171881A (de) 1984-01-15
DE2640358A1 (de) 1978-03-16
NL7709697A (nl) 1978-03-10
SE7710084L (sv) 1978-03-09
ES462065A1 (es) 1978-06-01
PT67014B (de) 1979-05-14
ATA643577A (de) 1981-05-15
ZA775405B (en) 1978-07-26
AT365181B (de) 1981-12-28
FR2364219A1 (fr) 1978-04-07
NZ185105A (en) 1979-12-11
JPS5334771A (en) 1978-03-31
US4174397A (en) 1979-11-13
HU175751B (hu) 1980-10-28

Similar Documents

Publication Publication Date Title
GB1592272A (en) Fused thiazolidine derivatives and process for their manufacture
EP0269378B1 (en) Quinazolinone derivative and processes for preparing the same
CS199280B2 (en) Method of producing novel esters of thiazolinyl-or thiazinyl-benzimidazole
US4150028A (en) Antiviral thiazolinyl benzimidazoles
Yale 3-Chloro-10-dialkylaminoalkylphenothiazines
CA1103245A (en) Process for the manufacture of novel oxadiazolopyrimidine derivatives
US3759938A (en) Thiazolidine derivatives
Zinnes et al. 1, 2-Benzothiazines. 6. 3-Carbamoyl-4-hydroxy-2H-1, 2-benzothiazine 1, 1-dioxides as antiinflammatory agents
IE44316B1 (en) Indazole derivatives
HU184976B (en) Process for preparing thiazoline derivatives and pharmaceutical compositions containing thereof
US4297365A (en) Benzimidazoles and pharmaceutical preparations containing such compounds
PL144860B1 (en) Method of obtaining novel derivatives of iminothiasolidyne
US3420823A (en) Dibenzothiazines
GB1571148A (en) Substituted ophenylenediamine derivatives processes for their preparation and their use as medicaments
US5071849A (en) Dihydropyrimidothiazine derivatives
KATZ et al. BENZOXAZOLE DERIVATIVES. II. 2-DIALKYLAMINO-ALKYLMERCAPTOBENZOXAZOLES
KR880001298B1 (ko) 벤조일-페닐-피페리딘 유도체의 제법
EP0093515B1 (en) Tricyclic triazino compounds, their use and formulation as pharmaceuticals and processes for their production
US2910505A (en) S-substituted n-benzhydryl pseudothioureas and their pseudothiouronium salts
EP0058009A1 (en) Novel benzanilide derivatives and pharmaceutical compositions containing them
US3962437A (en) 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
HU198023B (en) Process for production of new derivatives of benzamid and medical preparatives containing these compounds as active substance
JPS5924992B2 (ja) ピリド〔2,3−d〕ピリミジン誘導体およびその製法
US4018792A (en) 5-Cyano-thiophen-2-aldehyde-isothiosemicarbazones and process for preparing them
KR790001432B1 (ko) 티아졸리닐 또는 티아지닐 벤즈이미다졸 에스테르의 제조방법

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee